Cannabinoids exert a neuroprotective effect on the cognitive deficits caused by vascular dementia

By -
“Vascular dementia (VaD) is characteristic of chronic brain ischemia and progressive memory decline, which has a high incidence in the elderly”, states the study. “However, there are no effective treatments for VaD, and the underlying mechanism of its pathogenesis remains unclear.”
With that in mind, “This study investigated the effects of a synthetic cannabinoid receptor agonist WIN55,212-2 (WIN) on VaD, and molecular mechanisms of the effects.”
Using a variety of tests conducted on rat models, it was found that WIN55,212-2 – which is meant to mimic the effects of natural, cannabis-derived cannabinoids – “decreased the expression of Capase-3, and improved the learning and memory impairment of VaD rats.” Researchers state that “These data indicate that WIN exerts a neuroprotective effect on the cognitive deficits of VaD rats, which may be associated with the suppression of excessive autophagy and inflammation.”

Comments

Post a Comment

Popular posts from this blog

Heart risk calculator due for an update

By -
Image
Over 11 million Americans are at high risk of having a heart attack or  stroke  in the next 10 years — at least, that’s what the numbers say. The equation doctors use to estimate  cardiovascular  risk is prone to miscalculation, according to a new study, meaning patients may be popping daily aspirin or statins at the wrong dosage. The stakes are higher for African-Americans. With the old equation, 1 in 29 African-Americans may be incorrectly labeled very low or very high risk, according to the study. For example, a 46-year-old black man was estimated to have a 40 percent lower chance of having a heart attack or stroke than a white man of the same age and in identical health. In general, African-Americans are at higher risk of cardiovascular conditions than Caucasians, so miscalculations shouldn’t be taken lightly. The heart risk calculator transforms patient information — age, gender, race,  cholesterol  levels, blood pressure, prescriptions, and whether they are diabetic or a
Read more

Global Neurovascular Devices Market Growth Opportunities 2018 – , Medtronic, and Stryker Corporation

By -
Image
The research report on “Global Neurovascular Devices Market” reveals exclusive information regarding the leading players of neurovascular devices market, product launches, market segments, technological development,  neurovascular devices  industry chain structure and policies by region, along with five-year forecasts to assess how the market is anticipated to grow. neurovascular devices report delivers complete details about revenue generation by differing profiles of top leaders of neurovascular devices market. It also displays a comprehensive study of global neurovascular devices market competitive landscape, market drivers, challenges, and constraints, operator case studies, key developments and neurovascular devices market tendencies, future guidelines, methods and worth chain. Thereafter neurovascular devices report gives a precise summary of various growth opportunities, inventive business strategies, neurovascular devices product scope, market size, growth estimations,
Read more

How to Mend a Broken Heart

By -
Image
A newborn’s heart is about the size of its fist, the valves inside minuscule. This presents an issue for surgeons trying to help infants born with heart defects. Traditional mechanical replacement valves are larger than a newborn’s, so they may compress the coronary artery or trigger problems in the heart’s electrical system. And surgical repair is tricky because many infants have too little valve tissue to stitch together. “No matter what we try, it just doesn’t work,” says Carl Backer (pictured at top), head of cardiovascular surgery at the Ann & Robert H. Lurie Children’s Hospital of Chicago. Now there’s a more viable option: In March, the Food and Drug Administration approved the world’s smallest mechanical heart valve. Backer, who took the 15-millimeter device manufactured by Abbott Laboratories through clinical trials, first implanted one of the dime-size valves in 2011 under a “compassionate use” exemption, which allows doctors access to devices still in the process of ear
Read more